Spero Therapeutics SPRO
NASDAQ SPRO
$1.11 -0.02 (-1.77%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Cash & Current Investments (2016 - 2026)

Updated

Spero Therapeutics' Cash & Current Investments came in at $50.77 million for Q2 2026, up 62.8% from $31.19 million a year earlier but down 9.5% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Cash & Current Investments (2016 - 2026) Analysis & Trends

At the end of FY2025, Spero Therapeutics' Cash & Current Investments was $40.27 million, down 23.9% from FY2024.

  • Cash & Current Investments has declined in each of the last four years, with a five-year compound annual growth rate of -20.5% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $52.89 million in FY2024 (-30.7%), $76.33 million in FY2023 (-30.0%), $109.11 million in FY2022 (-25.5%) and $146.4 million in FY2021 (+15.4%).
  • The five-year range for quarterly Cash & Current Investments is $31.19 million (Q2 2025) to $146.4 million (Q4 2021).
  • Year-over-year, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 15.4%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2023 (growth of 86.0%), and the weakest in Q3 2022 (a decline of 59.1%).
  • Business Quant data shows SPRO's Cash & Current Investments at $56.13 million (Q1 2026), $40.27 million (Q4 2025) and $48.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Spero Therapeutics 63.77 Mn -132.02 Mn - 50.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.77 Mn
Mar 31, 2026 56.13 Mn
Dec 31, 2025 40.27 Mn
Sep 30, 2025 48.62 Mn
Jun 30, 2025 31.19 Mn
Mar 31, 2025 48.89 Mn
Dec 31, 2024 52.89 Mn
Sep 30, 2024 76.29 Mn
Jun 30, 2024 63.53 Mn
Mar 31, 2024 82.27 Mn
Dec 31, 2023 76.33 Mn
Sep 30, 2023 93.83 Mn
Jun 30, 2023 77.69 Mn
Mar 31, 2023 96.25 Mn
Dec 31, 2022 109.11 Mn
Sep 30, 2022 50.45 Mn
Jun 30, 2022 45.40 Mn
Mar 31, 2022 121.97 Mn
Dec 31, 2021 146.40 Mn
Sep 30, 2021 123.42 Mn
API Access

Spero Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SPRO&period=max&api_key=YOUR_API_KEY